Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing

Saum Sutaria, M.D.

👤 Person
762 total appearances

Appearances Over Time

Podcast Appearances

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

But the next 50 to 75 years, if that grows to 35% of the US economy, I think then you have some very, very serious arguments about how sustainable is that if the US economy doesn't grow as rapidly as it has been growing.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

But the next 50 to 75 years, if that grows to 35% of the US economy, I think then you have some very, very serious arguments about how sustainable is that if the US economy doesn't grow as rapidly as it has been growing.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Or a devaluation of the currency.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Or a devaluation of the currency.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

That's right. And that's the issue, right? Which is that ultimately, that's a very difficult proposition to actually get your head around and believe. And in particular, I think we should get into the outcomes in the US to explain what we're getting for all those dollars. You're right. It's very difficult to fathom expenditures getting to that level. Now, one...

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

That's right. And that's the issue, right? Which is that ultimately, that's a very difficult proposition to actually get your head around and believe. And in particular, I think we should get into the outcomes in the US to explain what we're getting for all those dollars. You're right. It's very difficult to fathom expenditures getting to that level. Now, one...

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

optimistic point of view on healthcare expenditure growth out there is that if you just look at the aging curve of the population, in particular the boomers and how they're growing and even with increasing lifespan, the aging of the population in the U.S. peaks at about 2032-ish timeframe. You can look at different projections.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

optimistic point of view on healthcare expenditure growth out there is that if you just look at the aging curve of the population, in particular the boomers and how they're growing and even with increasing lifespan, the aging of the population in the U.S. peaks at about 2032-ish timeframe. You can look at different projections.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

So in the next eight years, we're going to kind of reach the peak of aging. In other words, when I say aging, the number of people will grow every year that enter the above 65 Medicare world. And that number will peak and then will start to come down.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

So in the next eight years, we're going to kind of reach the peak of aging. In other words, when I say aging, the number of people will grow every year that enter the above 65 Medicare world. And that number will peak and then will start to come down.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

We will be right there. That's right. And then that number will start to come down. It's not just the boomers, obviously, but I'm just giving you the demographic. And the question is, when that comes down, will that mitigate this long-term trend of healthcare expenditure growth? So that's the optimistic view, that there is a mitigant built into the system just with the aging of the population.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

We will be right there. That's right. And then that number will start to come down. It's not just the boomers, obviously, but I'm just giving you the demographic. And the question is, when that comes down, will that mitigate this long-term trend of healthcare expenditure growth? So that's the optimistic view, that there is a mitigant built into the system just with the aging of the population.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Now, think about all of what you do. If at the same time, the consciousness and awareness of just basic interventions in health status can improve health status even a little bit from a chronic condition standpoint, because that's not going to be a one-year or two-year phenomenon. It takes a decade. Those two could together make a big difference in U.S. health care cost expenditures.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Now, think about all of what you do. If at the same time, the consciousness and awareness of just basic interventions in health status can improve health status even a little bit from a chronic condition standpoint, because that's not going to be a one-year or two-year phenomenon. It takes a decade. Those two could together make a big difference in U.S. health care cost expenditures.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

The challenge in terms of what's happening on the other side, especially in this context of debate around immigration, is we're not growing the population of people under 65 who generate the economic productivity to fund the system to get to 2032.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

The challenge in terms of what's happening on the other side, especially in this context of debate around immigration, is we're not growing the population of people under 65 who generate the economic productivity to fund the system to get to 2032.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

If you go back a number of years, like the 80s, and you look at the number of people pre-Medicare, so call it 40 to 65 years old to Medicare, it was two times the population.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

If you go back a number of years, like the 80s, and you look at the number of people pre-Medicare, so call it 40 to 65 years old to Medicare, it was two times the population.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Two times we're paying into- Well, I'm roughly saying highest economic productivity is 40 to 65. 40 to 65, yep. Two times the number of people as you had Medicare. That number is trending towards 1.0 by the time we hit 2032.

The Peter Attia Drive
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.

Two times we're paying into- Well, I'm roughly saying highest economic productivity is 40 to 65. 40 to 65, yep. Two times the number of people as you had Medicare. That number is trending towards 1.0 by the time we hit 2032.